Agenda
Wednesday, June 12, 2013
General Sessions
TAVR Day 1 (8:00 am - 6:00 pm)
Wednesday, June 12
8:00 am - 6:00 pm
Room: Bayshore Grand Ballroom
Session I. TAVR Year in Review
8:00 am - 9:30 am
Moderators: Alain G. Cribier, John G. Webb
Discussants: Todd M. Dewey, A. Pieter Kappetein, Susheel Kodali, Ganesh Manoharan, Jeffrey W. Moses, Thomas Walther
8:00 am
Welcome and Meeting Overview
8:05 am
The Annual "Mad Dash" Through the Recent TAVR Literature
8:25 am
Discussion with Audience Q&A
8:30 am
Aortic Bioskills 1
Lead Discussant: Mark Reisman
8:45 am
Live Case 1: University Heart Center Hamburg (Hamburg, Germany)
Session II. TAVR Global "Landscape" Perspectives
9:30 am - 12:00 pm
Moderators: A. Pieter Kappetein, Martin B. Leon
Discussants: David J. Cohen, Helene Eltchaninoff, Neil E. Moat, Martyn R. Thomas, Alec S. Vahanian, Olaf Wendler
9:30 am
TAVR Penetration and Clinical Outcomes: Observations from EU Experiences and the GARY Registry
9:42 am
Discussion with Audience Q&A
Updates from the US TAVR Commercial Release
9:45 am
Site Training Experiences
9:53 am
Early Insights from the TVT Registry
10:01 am
Discussion
The Heart Team Revisited: Point-Counterpoint
10:05 am
Thriving and Needed More Than Ever
10:13 am
An Artificial Construct Doomed to Extinction
10:21 am
Discussion
TAVR Patient Selection Controversies: Frailty, Futility, and Risk Creep
10:25 am
The Use and Misuse of Risk Scores
10:33 am
How I Select Patients for TAVI in Rouen
10:41 am
Discussion
10:45 am
TAVR Cost-effectiveness and Reimbursement: A Global Gordian Knot
10:57 am
Discussion with Audience Q&A
11:00 am
Aortic Bioskills 2
Lead Discussant: Mark Reisman
11:15 am
Live Case 2: St. Paul's Hospital (Vancouver, Canada)
Session III
12:00 pm - 2:00 pm
Moderators: Eberhard Grube, Mathew Williams
Discussants: Lutz Buellesfeld, James B. Hermiller Jr, Samir R. Kapadia, Georg Nickenig, Michael J. Reardon, Chet Rihal, Corrado Tamburino
Challenging Case Winners 1: Best Cases of the Year
12:00 pm
First-in-human case with a dedicated fully percutaneous TAVR system for pure aortic insufficiency
Case Presenter: Marco Barbanti
12:10 pm
Discussion
12:15 pm
Mitral Valve-in-Valve-in-Valve
Case Presenter: Danny Dvir
12:25 pm
Discussion
12:30 pm
Successful Percutaneous Aortic Valve Closure To Treat Left Ventricular Assist Device - Associated Aortic Insufficiency
Case Presenter: Jean-Michel Paradis
12:40 pm
Discussion
12:45 pm
Melody Valve Implantation into an LV to Ascending Aorta Conduit with Failing Bioprosthesis
Case Presenter: Mario Goessl
12:55 pm
Discussion
1:00 pm
Imaging Skills 1: Echocardiography Essentials for TAVR
1:15 pm
Live Case 3: McGill University Health Centre (Montreal, Canada)
Session IV. TAVR Complications and Vexations
2:00 pm - 4:00 pm
Moderators: Thierry Lefevre, Martyn R. Thomas
Discussants: Anita Asgar, Philippe Généreux, Francesco Maisano, Helge Moellmann, Steven J. Yakubov
Conduction System Disturbances and Pacemakers
2:00 pm
Incidence and Predictors After TAVR
2:10 pm
Scenario-Based Management Recommendations
2:20 pm
Discussion
Annulus Sizing and PVL
2:30 pm
Methods and Guidelines for Optimal TAVR Annulus Sizing
2:40 pm
Perspectives on Post-TAVR Paravalvular Leaks
2:50 pm
Discussion
Vascular Complications and Access Alternatives
3:00 pm
Best Clinical Practices for Transfemoral TAVR
3:10 pm
Non-transfemoral Access Alternatives
3:20 pm
Discussion
Strokes After TAVR
3:30 pm
Incidence, Timing, and Insights
3:40 pm
Predictors and Contributing Factors
3:50 pm
Discussion
Session V. AS Complex Case Management Workshop
4:00 pm - 6:00 pm
Moderators: Patrick T. O'Gara, Allan Schwartz
Discussants: Rebecca T. Hahn, James B. Hermiller Jr, Thierry Lefevre, Philippe Pibarot, Augusto D. Pichard, E. Murat Tuzcu
Low Flow, Low Gradient AS
4:00 pm
Case Presentation
Case Presenter: Isaac George
4:05 pm
Thoughtful Commentary
Discussant: Philippe Pibarot
4:15 pm
Discussion
AS with Simple and Complex CAD
4:20 pm
Case Presentation
Case Presenter: Jean-Michel Paradis
4:25 pm
Thoughtful Commentary
Discussant: James B. Hermiller Jr
4:35 pm
Discussion
AS and MR
4:40 pm
Case Presentation
Case Presenter: Ted E. Feldman
4:45 pm
Thoughtful Commentary
Discussant: Marco Barbanti
4:55 pm
Discussion
Severe Asymptomatic AS
5:00 pm
Case Presentation
Case Presenter: David A. Wood
5:05 pm
Thoughtful Commentary
Discussant: Patrick T. O'Gara
5:15 pm
Discussion
AS with Severe COPD
5:20 pm
Case Presentation
Case Presenter: Danny Dvir
5:25 pm
Thoughtful Commentary
Discussant: Vinod H. Thourani
5:35 pm
Discussion
AS with Severe LV Dysfunction
5:40 pm
Case Presentation
Case Presenter: Tamim Nazif
5:45 pm
Thoughtful Commentary
Discussant: Allan Schwartz
5:55 pm
Discussion
Workshops
Challenging Cases I (10:30 am - 11:45 am)
Wednesday, June 12
10:30 am - 11:45 am
Room: Stanley Park Ballroom, Salon 1-3, 2nd Floor
Agenda
10:30 am - 11:45 am
Moderators: Lutz Buellesfeld, Todd M. Dewey
Discussants: Nirat Beohar, Louis A. Cannon, Stephan M. Ensminger, Christopher U. Meduri
10:30 am
Paravalvular Leak Closure For Persisting Aortic Regurgitation after implantation of the CoreValve Transcatheter Valve
Case Presenter: Petra Poliacikova
10:40 am
Discussion
10:45 am
Transseptal Strategies in Challenging Transcatheter Aortic Valve-in-Valve Implantation
Case Presenter: Simon Cheung Chi Lam
10:55 am
Discussion
11:00 am
An Anticoagulated Patient with Severe Paravalvular Regurgitation and Ostial Left Main Disease
Case Presenter: Peter Pollak
11:10 am
Discussion
11:15 am
A Direct Flow Medical Transcatheter Aortic Valve Implantation Case: Repositioning to Optimize Result and Echo Assessment Prior to Final Implantation
Case Presenter: Federico De Marco
11:25 am
Discussion
11:30 am
Percutaneous Coronary Intervention with Rotablation Atherectomy to Calcified Diffusely Diseased Left Anterior Descending Coronary Artery in a 90 Year Old Patient Through CoreValve Struts
Case Presenter: Mark Aziz
11:40 am
Discussion
How-to Workshop I. Vascular Access and Closure: TF Only (2:00 pm - 3:30 pm)
Wednesday, June 12
2:00 pm - 3:30 pm
Room: Cypress Room 1, 2nd Floor
Agenda
2:00 pm - 3:30 pm
Moderators: Mathew Williams, David A. Wood
Discussants: Louis A. Cannon, Ganesh Manoharan, Ian T. Meredith, Augusto D. Pichard
2:00 pm
Vascular Complications: PARTNER Outcomes and Review of the Literature
2:10 pm
Access Screening for TAVR: Who Should and Shouldn't Be Transfemoral Candidates
2:18 pm
Optimal Femoral Access: Variations on How To Do It
Percutaneous Suture-Based Femoral Artery Closure: How Do I Do It? Tips and Tricks
2:26 pm
Columbia University Medical Center (New York, NY)
2:34 pm
Melbourne, Australia
2:42 pm
Vancouver, Canada
2:50 pm
University of Bonn (Bonn, Germany)
2:58 pm
Managing Transfemoral Access Complications: Strategies and Toolbox (Case Examples)
3:08 pm
Are There Indications for Direct Surgical Femoral Artery Cutdown and Repair?
3:16 pm
Discussion with Audience Q&A
New Technology I. Post-TAVR Stroke Issues and Cerebral Protection Devices (2:00 pm - 3:30 pm)
Wednesday, June 12
2:00 pm - 3:30 pm
Room: Stanley Park Ballroom, Salon 1-3, 2nd Floor
Stroke Issues
2:00 pm - 2:36 pm
2:00 pm
Taking Strokes Seriously: Definitions (VARC 2), Stroke Grading Scores, Study Endpoints, Neuroimaging, and Neurocognitive Function
2:08 pm
Stroke Frequency and Timing after TAVR: Evolving Insights from the PARTNER Database
2:18 pm
Predictors of TAVR: Associated Strokes: New Onset Atrial Fibrillation, Postdilatation, and Others
2:28 pm
Pharmacotherapy Alternatives During and After TAVR: Is There an Optimal Regimen?
Cerebral Protection Devices
2:36 pm - 3:30 pm
2:36 pm
The Embrella Deflector Device: Technology and Early Clinical Experiences
2:44 pm
Status Update of the PROTAVI C Trial in EU
2:52 pm
The Claret Montage Filter Device: Technology and Early Clinical Experiences
3:00 pm
Pathoanatomic Findings from Filtered Debris After TAVR
3:08 pm
The Keystone Deflector Device: Technology and Early Clinical Experiences
3:18 pm
Discussion with Audience Q&A
Best of Bioskills IV. Interatrial Septum, Left Atrial Appendage, and Transseptal (4:00 pm - 5:30 pm)
How-to Workshop II. Patient Selection Controversies for TAVR (eg, Frailty, Futility) (4:00 pm - 5:30 pm)
Wednesday, June 12
4:00 pm - 5:30 pm
Room: Cypress Room 1, 2nd Floor
Risk Scores
4:00 pm - 4:34 pm
4:00 pm
The "Essential Primer" on Surgical Risk Scores: Key Take-home Messages
4:10 pm
Did STS Score or EuroScore Risk Profiles Predict Mortality Outcomes in PARTNER?
4:18 pm
Risk Profiling Schemes Used in the US CoreValve Trial
4:26 pm
How Does the Heart Team Use Risk Scores and Other Parameters to Categorize Patients for TAVR in the European Union?
Frailty
4:34 pm - 5:00 pm
4:34 pm
Defining and Measuring Frailty in Aortic Stenosis Patients: From the Eyeball Test to Objective Tools
4:44 pm
Baseline Frailty Status of the "Extreme Risk" Patients in the US CoreValve Trial
4:52 pm
Frailty Predictors of Clinical Outcomes in TAVR Patients: Early Insights
Futility
5:00 pm - 5:16 pm
5:00 pm
Using Quality-of-Life Metrics to Develop a Futility Model in TAVR Patients
5:08 pm
Retrospective Analysis of Poor Outcome Groups from the PARTNER Trial
Intermediate Risk
5:16 pm - 5:30 pm
Should Intermediate-Risk AS Patients (STS Score 4% to 8%) Receive TAVR in 2013?
5:16 pm
Absolutely Not (Rare Exceptions)!
5:23 pm
Many Are Good Candidates Today!
New Technology II. New Sheaths, Vascular Closure Devices, Transapical Access Closure Technologies, and Balloon Valvuloplasty Systems (4:00 pm - 5:30 pm)
Wednesday, June 12
4:00 pm - 5:30 pm
Room: Stanley Park Ballroom, Salon 1-3, 2nd Floor
Sheaths and Vascular Closure Devices
4:00 pm - 4:36 pm
4:00 pm
New Sheath Technologies for Transfemoral Access: Advantages and Limitations
4:08 pm
The Landscape of Dedicated Transfemoral Closure Devices for TAVR
4:20 pm
Not So Fast! Current Suture-Based Transfemoral Closure Devices Are More Than Adequate: The Vancouver Experience
4:28 pm
Discussion with Audience Q&A
Trans-apical Access-Closure Technologies
4:36 pm - 5:26 pm
4:36 pm
Are Dedicated Transcutaneous LV Apical Access Closure Technologies Important to "Revive" the TA-TAVR Procedure?
4:44 pm
A Whirlwind Tour of the New LV Apical Access Closure Devices: Focus on Technology
4:56 pm
Early Clinical Experiences with the Apica TA-TAVR System
5:04 pm
Early Clinical Experiences with the Entourage TA-TAVR System
5:12 pm
Discussion with Audience Q&A
Balloon Valvuloplasty Systems
5:20 pm - 5:30 pm
5:20 pm
A Review of New Balloon Aortic Valvuloplasty Systems: InterValve Loma Vista, Cardiosculpt, and PiR2
Thursday, June 13, 2013
General Sessions
TAVR Day 2 (8:00 am - 2:00 pm)
Thursday, June 13
8:00 am - 2:00 pm
Room: Bayshore Grand Ballroom
Session VI. New TAVR System
8:00 am - 9:30 am
Moderators: Neil E. Moat, Josep Rodes-Cabau
Discussants: Alexandre Abizaid, Joerg Kempfert, Jean-Claude Laborde, Raj Makkar, Ian T. Meredith, Joachim Schofer
8:00 am
An Overview of the New and Novel TAVR Systems
8:20 am
Discussion with Audience Q&A
8:30 am
Aortic Bioskills 3
Lead Discussant: Mark Reisman
8:45 am
Live Case 4: University Heart Center Hamburg (Hamburg, Germany)
Session VII. Expanding TAVR Clinical Indications
9:30 am - 10:30 am
Moderators: Susheel Kodali, Olaf Wendler
Discussants: Vinayak Bapat, Ronald K. Binder, Danny Dvir, Philippe Généreux, Patrick T. O'Gara, Nicolas M. van Mieghem
Valve-in-Valve for Bioprosthetic Valve Failure
9:30 am
Rationale, Technical Requirements, and Procedural Considerations
9:40 am
Update from the Global Valve-in-Valve TAVR Registry
9:50 am
Discussion
Intermediate-Risk AS Patients
10:00 am
TAVR in Intermediate Risk Patients in EU: Reasonable and Appropriate vs. Unwarranted "Risk Creep"
10:08 am
Updates from PARTNER 2A
10:16 am
Updates from SURTAVI
10:24 am
Discussion
Session VIII. TAVR Evidence-Based Medicine Corner I
10:30 am - 12:00 pm
Moderators: Martin B. Leon, Axel Linke
Discussants: Nirat Beohar, Danny Dvir, Philippe Généreux, Patrick T. O'Gara, Augusto D. Pichard, Allan Schwartz
10:30 am
VARC 2 Updates and TAVR Clinical Outcomes Using VARC Definitions
10:40 am
Discussion
10:43 am
A Summary of New PARTNER Results from the PARTNER Publications Office (Recent Abstracts and Manuscripts)
10:57 am
Discussion
11:00 am
Aortic Bioskills 4
11:15 am
Live Case 5: McGill University Health Centre (Montreal, Canada)
Session IX
12:00 pm - 2:00 pm
Moderators: Jeffrey J. Popma, Mark Reisman
Discussants: Vasilis Babaliaros, John D. Carroll, Karl-Heinz Kuck, Jonathon A. Leipsic, Mathew Williams
Challenging Case Winners 2: TAVR Complications - Rich Emotional Experiences
12:00 pm
Severe Paravalvular Leak After CoreValve: Percutaneous Closure With Amplatzer Vascular Plugs
Case Presenter: Sameer Gafoor
12:10 pm
Discussion
12:15 pm
Treatment of right coronary artery occlusion after CoreValve implantation
Case Presenter: Corrado Tamburino
12:25 pm
Discussion
12:30 pm
Progressive Transvalvular Aortic Regurgitation After Transcatheter Aortic Valve Replacement
Case Presenter: Fernando Javier Pineda A
12:40 pm
Discussion
12:45 pm
Successful Endovascular Repair of Left Subclavian Rupture After TAVI Implantation
Case Presenter: Daniel Garcia
12:55 pm
Discussion
1:00 pm
Imaging Skills 2: CTA Essentials for TAVR
1:15 pm
Live Case 6: St. Paul's Hospital (Vancouver, Canada)
Mitral Day 1 (2:00 pm - 6:00 pm)
Thursday, June 13
2:00 pm - 6:00 pm
Room: Bayshore Grand Ballroom
Session I. Mitral Valve Therapies Overview
2:00 pm - 3:55 pm
Moderators: A. Pieter Kappetein, Gregg W. Stone
Discussants: David H. Adams, Steven F. Bolling, John D. Carroll, Charles J. Davidson, Patrick T. O'Gara, Allan Schwartz
2:00 pm
Mitral Valve Therapies: The Year in Review
2:30 pm
Discussion with Audience Q&A
2:40 pm
Bioskills Presentation: Normal Mitral Valve Anatomy
Discussant: Mark Reisman
2:50 pm
A Primer of Echcardiographic Mitral Valve Assessment: Views, Pathology, and Disease Quantification
3:10 pm
Indications for Surgical and Transcatheter Intervention and in Degenerative and Functional MR: US Guidelines and Perspectives
3:25 pm
Indications for Surgical and Transcatheter Intervention and in Degenerative and Functional MR: EU Guidelines and Perspectives (and Contrasts with the US)
3:40 pm
Discussion with Audience Q&A
Session II. Degenerative MR
3:55 pm - 6:00 pm
Moderators: Michael J. Mack, Allan Schwartz
Discussants: Ted E. Feldman, Paul A. Grayburn, Brad I. Munt, Michael J. Reardon, Mark Reisman
3:55 pm
The Spectrum of Surgical Approaches in Degenerative MR: Does Technique, Skill, and Valve Type Matter?
4:10 pm
Early and Late Outcomes After Surgery in Degenerative MR: A Critical Appraisal
4:25 pm
Discussion with Audience Q&A
4:35 pm
Bioskills Presentation: MitraClip Technique and Pathology
Discussant: Mark Reisman
4:45 pm
Taped Case 1: MitraClip in Degenerative MR
Case Presenter: Saibal Kar
5:05 pm
MitraClip Outcomes in Degenerative MR (Low- and High-Risk Surgical Patients): Lessons Learned and Appropriate Patients
5:25 pm
Taped Case 2: MitraClip in Degenerative MR
5:45 pm
Discussion with Audience Q&A
Workshops
MitraClip Technique: An Operator's Guide (8:00 am - 12:00 pm)
Thursday, June 13
8:00 am - 12:00 pm
Room: Stanley Park Ballroom, Salon 3, 2nd Floor
Session I. Case Selection and Echo Imaging
8:00 am - 9:09 am
Moderators: Ted E. Feldman, Samir R. Kapadia
Discussants: Paul A. Grayburn, Rebecca T. Hahn, Saibal Kar
8:00 am
Step-by-Step Echo Imaging for Evaluation of MR
8:15 am
Quantification of MR
8:30 am
Atrial Septal Puncture for the MitraClip
8:42 am
Mitral Valve Anatomy for the MitraClip: Optimal
8:57 am
Discussion with Audience Q&A
Session II. MitraClip Procedural Steps
9:09 am - 10:20 am
Moderators: Rebecca T. Hahn, Saibal Kar
Discussants: John D. Carroll, William A. Gray, Francesco Maisano
9:09 am
Understanding the MitraClip Device
9:20 am
Optimizing Echo and Fluoro Imaging During the MitraClip Procedure
9:35 am
The MitraClip Procedure Step by Step
9:50 am
Procedural Techniques for Various Mitral Pathologies
10:05 am
Discussion with Audience Q&A
Session III. MitraClip Challenges and Complications
10:20 am - 12:00 pm
Moderators: James B. Hermiller Jr, Scott Lim
Discussants: Jason H. Rogers, Carlos E. Ruiz, Corrado Tamburino, Brian K. Whisenant
10:20 am
Potential Complications of the MitraClip Procedure
10:35 am
My Most Challenging MitraClip Case
Case Presenter: Corrado Tamburino
10:47 am
My Greatest MitraClip Success
10:59 am
My Worst MitraClip Case
Case Presenter: Carlos E. Ruiz
11:11 am
My Worst MitraClip Complication
11:23 am
Surgery Following a Failed MitraClip Procedure: Truth Be Told
11:35 am
Discussion with Audience Q&A
How-to Workshop III. Vascular Access and Closure: Non-TF Approaches (TA, Direct Ao, and Beyond) (8:30 am - 10:00 am)
Thursday, June 13
8:30 am - 10:00 am
Room: Seymour Room, Lobby Level
Agenda
8:30 am - 10:00 am
Moderators: Todd M. Dewey, Mathew Williams
Discussants: Vasilis Babaliaros, Isaac George, Augusto D. Pichard, Vinod H. Thourani
8:30 am
Transapical Approach: Advantages, Disadvantages, and How I Do It
8:45 am
Siubclavian Axillary Approach: Advantages, Disadvantages, and How I Do It
9:00 am
Direct Aortic Approach: Advantages, Disadvantages, and How I Do It
9:15 am
Direct Iliac Access: Advantages, Disadvantages, and How I Do It
9:25 am
Transvenous Transeptal Antegrade ApproachA Return to the Past? A Viable Alternative in the "Modern Era"
9:35 am
Carotid Access for TAVR: Are You Kidding?
9:45 am
Discussion: A Sensible Algorithm for Non-TF Access for TAVR
New TAVR Systems I. Edwards Lifesciences and Medtronic (8:30 am - 10:00 am)
Thursday, June 13
8:30 am - 10:00 am
Room: Stanley Park Ballroom, Salon 1-2, 2nd Floor
Edwards Lifesciences
8:30 am - 9:15 am
Moderators: John G. Webb, Jian Ye
Discussants: Vinayak Bapat, Ronald K. Binder, Eberhard Grube, Karl-Heinz Kuck, Martyn R. Thomas
The Sapien 3 TAVR System
8:30 am
Technology Review
8:35 am
Clinical Results
8:40 am
Case Examples
The Centera Self-Expanding TAVR System
8:50 am
Technology Review
8:55 am
Clinical Results
9:00 am
Case Examples
Case Presenter: Eberhard Grube
The Helio Docking TAVR System for Aortic Insufficiency
9:05 am
Technology Review
9:08 am
Clinical Results
9:11 am
Case Examples
Medtronic
9:15 am - 10:00 am
Moderators: Joerg Kempfert, Jeffrey J. Popma
Discussants: Eberhard Grube, Jean-Claude Laborde, Axel Linke, Ganesh Manoharan, Michael J. Reardon, Thomas Walther
The CoreValve Evolut TAVR System
9:15 am
Technology Review
9:20 am
Clinical Results
9:25 am
Case Examples
The Engager TA-TAVR System
9:35 am
Technology Review
9:40 am
Clinical Results
9:45 am
Case Examples
New Accessories (In-line Sheath/Catheter and Dedicated Guidewires)
9:55 am
Technology Review
Challenging Cases II (10:30 am - 12:00 pm)
Thursday, June 13
10:30 am - 12:00 pm
Room: Oak Room, 2nd Floor
Agenda
10:30 am - 12:00 pm
Moderators: Jeffrey W. Moses, Chet Rihal
Discussants: Maurice Buchbinder, Isaac George, Fabian Nietlispach, Steven J. Yakubov
10:30 am
Combined transapical and transfemoral approaches for challenging simultaneous mitro-aortic paravalvular leak closure
Case Presenter: Francesco Maisano
10:40 am
Discussion
10:45 am
Antegrade Transcatheter Aortic Valve Replacement Utilizing Femoral Venous and Bilateral Upper Extremity Arterial Access
Case Presenter: Justin P Levisay
10:55 am
Discussion
11:00 am
Mitral Valve Replacement With The Sapien XT On Fibrillating Heart (In Previously Implanted Aortic Corevalve®)
Case Presenter: Enrico Ferrari
11:10 am
Discussion
11:15 am
Novel Sliding Balloon Technique in TAVR in patients with Horizontal Porcelain Aortas
Case Presenter: Puvi Seshiah
11:25 am
Discussion
11:30 am
Transfemoral TAVR in a patient with Bioprosthetic Mitral valve and LV dysfunction
Case Presenter: Puvi Seshiah
11:40 am
Discussion
11:45 am
Cardiogenic Shock due to Severe Ischemic Mitral Regurgitation: MitraClip Therapy as a Bridge to Surgical Intervention
Case Presenter: Anita Asgar
11:55 am
Discussion
How-to Workshop IV. Valve Sizing and Management of Intraprocedural PVL (10:30 am - 12:45 pm)
Thursday, June 13
10:30 am - 12:45 pm
Room: Seymour Room, Lobby Level
Valve Sizing
10:30 am - 11:43 am
Discussants: Vasilis Babaliaros, Raj Makkar, Jeffrey J. Popma, Alec S. Vahanian
10:30 am
Use of the "Cover Index" for Valve Sizing to Predict PVL After TAVR
10:38 am
A Prospective Multicenter Evaluation of CT Sizing for TAVR
10:46 am
CT Sizing Algorithms for Balloon-Expandable Valves: Methodology, Guidelines, and Helpful Tips
10:54 am
CT Sizing Algorithms for Self-Expanding Valves: The US CoreValve Experience
11:02 am
Balloon Sizing Facilitates Valve Selection for TAVR
11:10 am
Balloon Undersizing as Part of a CT Sizing Strategy: CT Assessment of THV Expansion and Correlation with PVL
11:18 am
The Use and Value of 3-D TEE During TAVR for (1) Valve Sizing and (2) THV Positioning
11:30 am
Comparison of CT and 3-D TEE for THV Sizing and Prevention of PVL
11:38 am
Discussion with Audience Q&A
Intra-procedure PVL
11:43 am - 12:42 pm
Discussants: Samir R. Kapadia, Susheel Kodali, Thierry Lefevre, Georg Nickenig, Josep Rodes-Cabau
11:43 am
Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR: A Recent Meta-Analysis
11:53 am
Hemodynamic Assessment of PVL after TAVR: Using the AR Index to Define Severity and Guide Therapy
12:03 pm
Echo Assessment of PVL After TAVR: Definitions and Guidelines for Treatment
Post-Dilatation to Reduce PVL After TAVR
12:13 pm
The French Experience
12:21 pm
Concerns from Canada
12:29 pm
The US-Columbia Strategy
12:37 pm
Discussion with Audience Q&A
New TAVR Systems II. Symetis, Direct Flow Medical, and JenaValve (10:30 am - 12:00 pm)
Thursday, June 13
10:30 am - 12:00 pm
Room: Stanley Park Ballroom, Salon 1-2, 2nd Floor
Symetis: ACURATE TA and ACURATE TF
10:30 am - 11:00 am
Moderator: Thomas Walther
Discussants: Alexandre Abizaid, Helge Moellmann
Technology and Clinical Results
10:30 am
ACURATE Transapical
10:40 am
ACURATE Transfemoral
10:50 am
Case Examples
Direct Flow Medical: TF
11:00 am - 11:30 am
Moderator: Joachim Schofer
Discussants: Charles J. Davidson, Francesco Maisano, E. Murat Tuzcu
11:00 am
Technology Review
11:10 am
Clinical Results: The Discover Trial
11:20 am
Case Examples
JenaValve: TA
11:30 am - 12:00 pm
Moderators: Stephan M. Ensminger, Ardawan Rastan
11:30 am
Technology Review
11:40 am
Clinical Results The Jupiter Registry and AR Results
11:50 am
Case Examples
Special Session I. Health Economics and Reimbursement: Global Perspectives (10:30 am - 12:05 pm)
Thursday, June 13
10:30 am - 12:05 pm
Room: Cypress Room 1, 2nd Floor
Health Economics and Reimbursement: Global Perspectives
10:30 am - 12:03 pm
10:30 am
Can We Afford TAVR? Impact on US Hospitals and Health Systems: Lessons from PARTNER and Beyond
10:45 am
Cost-effectiveness of Surgical AVR vs. TAVR Using Registry Data
10:55 am
The Impact of Reimbursement on TAVR Utilization in Europe
Economic Consequences of TAVR in US Hospitals: Case Examples
11:05 am
Dallas, TX
11:13 am
Atlanta, GA
11:21 am
A Primer on Billing and Reimbursement in the United States: Tips, Pitfalls, and Realities
11:31 am
Why Does TAVR Cost So Much? Perspectives from the Medical Device Industry
11:41 am
Novel Reimbursement Models and the Impact on New Technology
11:53 am
Discussion with Audience Q&A
How-to Workshop V. Percutaneous Closure of Paravalvular Leaks (2:00 pm - 3:30 pm)
Thursday, June 13
2:00 pm - 3:30 pm
Room: Seymour Room, Lobby Level
Agenda
2:00 pm - 3:30 pm
Moderators: Samir R. Kapadia, Chet Rihal
Discussants: Scott Lim, Carlos E. Ruiz, Brian K. Whisenant, Mathew Williams
2:00 pm
A Comprehensive Overview of Paravalvular Leak Closure: Techniques, and Clinical Outcomes
2:15 pm
Step-by-Step Approach to Aortic Paravalvular Leak Closure (Including Case Presentations
2:30 pm
Transseptal Closure of Mitral Paravalvular Leaks (Including Case Presentations)
2:40 pm
Percutaneous Apical Closure of Mitral Paravalvular Leaks (Including Case Presentations)
2:50 pm
Transthoracic Apical Closure of Mitral Paravalvular Leaks, with TEE guidance (Including Case Presentations)
3:00 pm
Paravalvular Leak Closure After TAVR: Indications and Technical Insights
3:10 pm
Discussion with Audience Q&A
New TAVR Systems III. Sadra Medical, St. Jude Medical, Others (2:00 pm - 3:40 pm)
Thursday, June 13
2:00 pm - 3:40 pm
Room: Stanley Park Ballroom, Salon 1-3, 2nd Floor
St. Jude's Portico: TF and TA
2:00 pm - 2:30 pm
Moderator: Ganesh Manoharan
Discussants: Francesco Maisano, Raj Makkar, Martyn R. Thomas
2:00 pm
Technical Review
2:10 pm
Clinical Results
2:20 pm
Case Examples
Sadra Medical: TF
2:30 pm - 3:00 pm
Moderator: Ian T. Meredith
Discussants: Ted E. Feldman, Eberhard Grube
2:30 pm
Technical Review
2:40 pm
Clinical Results from Reprise I and II
2:50 pm
Case Examples
Others
3:00 pm - 3:40 pm
Moderators: Martin B. Leon, Martyn R. Thomas
3:00 pm
The Colibri TAVR System
3:08 pm
The Inovare TAVR System (Braile Biomedical, Brazil)
3:16 pm
The Venus TAVR System (Venus MedTec, China)
3:24 pm
The Valve Medical TAVR System (Israel)
3:30 pm
The Thubikar TAVR system
3:36 pm
Discussion
How-to Workshop VI. Procedural Considerations (eg, Balloon Valvuloplasty, Anesthesia Monitoring, New Pacemakers) and Important (but Often Less Common) TAVR Complications (4:00 pm - 6:00 pm)
Thursday, June 13
4:00 pm - 6:00 pm
Room: Seymour Room, Lobby Level
Procedural Considerations
4:00 pm - 4:57 pm
Discussants: Eberhard Grube, Rebecca T. Hahn, Tamim Nazif, Fabian Nietlispach, David A. Wood
4:00 pm
TAVR "Redux:" Cath Lab Setting, Necessary Staffing, No General Anesthesia, TTE and Surgery as Needed, and Early Discharge
4:10 pm
TAVR "Extraordinaire:" My Compelling Case to Preserve TEE as Fundamental to TAVR
4:18 pm
Ad-hoc TAVI, Ad-hoc Coronary Stenting, and Ad-hoc LAA Closure
4:28 pm
Direct TAVR Without Predilatation: Rationale and Results
4:36 pm
Interpretation, Frequency, and Management Strategy of Conduction Abnormalities During TAVR
4:46 pm
The 3M Approach to TAVR Permits Safe Next Day Discharge in High Risk Patients
4:52 pm
Discussion with Audience Q&A
Important TAVR Complications
4:57 pm - 6:00 pm
Discussants: Marco Barbanti, Philippe Généreux, Rebecca T. Hahn, Susheel Kodali, Josep Rodes-Cabau
4:57 pm
Predicting Complications after TAVR: Are we there Yet?
5:05 pm
Bleeding Complications After TAVR (and SAVR): An Often Misunderstood and Neglected Complication
5:15 pm
Coronary Occlusion After TAVR: Review of a Multicenter Experience
5:25 pm
A Mulitcenter Evaluation of Annulus Rupture After TAVR: Preprocedural CT Risk Factors
5:35 pm
Case Series of Valve Thrombus After TAVR: Clinical Recognition and Management
5:43 pm
Interesting Echo Complications After TAVR: VSDs and Peri-aortic Hematomas
5:53 pm
Discussion with Audience Q&A
New Technology III. Hybrid Cath Lab/OR and Advanced Imaging Systems (4:00 pm - 5:30 pm)
Thursday, June 13
4:00 pm - 5:30 pm
Room: Stanley Park Ballroom, Salon 1-3, 2nd Floor
Hybrid Cath Lab/OR
4:00 pm - 4:30 pm
4:00 pm
Advantages and Design Requirements of a Hybrid Cath Lab/OR for TAVR (and Other Complex) Procedures
4:15 pm
A Standard Cath Lab Is Sufficient for TAVR Procedures: Rouen and FRANCE 2 Experiences
4:25 pm
Discussion with Audience Q&A
Advanced Imaging
4:30 pm - 5:30 pm
4:30 pm
The Optimal Imaging Environment for TAVR Procedures: General Considerations and Alternatives
4:38 pm
The Philips Heart Navigator System and Fluoroscopic Coregistration
4:46 pm
The GE Innova Vision System
4:54 pm
The Siemens Dyna-CT System
5:02 pm
The Paieon Angiographic Analysis and Positioning System: Utility and Analytical Observations
5:12 pm
New Intraprocedural Echo Systems for TAVR: 3-D, ICE, Micro, and New Software
5:22 pm
Discussion with Audience Q&A
Friday, June 14, 2013
General Sessions
TAVR Day 3 (8:00 am - 2:00 pm)
Friday, June 14
8:00 am - 2:00 pm
Room: Bayshore Grand Ballroom
Session X. New TAVR Accessory Devices
8:00 am - 9:30 am
Moderators: Eberhard Grube, Vinod H. Thourani
Discussants: Alexandre Abizaid, Alain G. Cribier, Helene Eltchaninoff, James B. Hermiller Jr, Thierry Lefevre, Josep Rodes-Cabau
8:00 am
Cerebral Embolic Protection Devices
8:12 am
Discussion with Audience Q&A
8:15 am
New Access and Closure Devices: Vascular and LV Apical
8:21 am
New Access and Closure Devices: Vascular and LV Apical
8:27 am
Discussion with Audience Q&A
8:30 am
Aortic Bioskills 5
Lead Discussant: Mark Reisman
8:45 am
Live Case 7: St. Paul's Hospital (Vancouver, Canada)
Session XI. TAVR Procedural Considerations
9:30 am - 10:30 am
Moderators: Alain G. Cribier, Jean-Claude Laborde
Discussants: Vasilis Babaliaros, Joerg Kempfert, Thierry Lefevre, Ganesh Manoharan, Fabian Nietlispach, Michael J. Reardon
9:30 am
Pre- and Post-Dilatation Considerations: Strategic Decision Making
9:40 am
Discussion with Audience Q&A
9:45 am
"Minimalist" Approach: No General Anesthesia, Transthoracic Echo and Surgeons, "As Needed"
9:55 am
Discussion with Audience Q&A
10:00 am
Pearls on Vascular Access Choices
10:10 am
Discussion with Audience Q&A
10:15 am
The Case for the Hybrid OR-Cath Lab
10:25 am
Discussion with Audience Q&A
Session XII. TAVR Evidence-Based Medicine Corner II
10:30 am - 12:00 pm
Moderators: Martin B. Leon, Jeffrey J. Popma
Discussants: Anita Asgar, Marco Barbanti, Karl-Heinz Kuck, Michael J. Reardon, Corrado Tamburino, Nicolas M. van Mieghem
10:30 am
Featured Lecture: Baseline Patient Characteristics from the US CoreValve Clinical Trial
10:45 am
Discussion with Audience Q&A
10:50 am
Updates from the Edwards SOURCE Registries
11:00 am
Updates from the ADVANCE CoreValve Registry
Key Vignettes from the TAVR Country Registries
11:10 am
United Kingdom
11:20 am
France
11:30 am
Italy
11:40 am
Canada
11:50 am
Discussion: The Value of TAVR Registries
Session XIII.
12:00 pm - 2:00 pm
Moderators: Mark Reisman, Allan Schwartz
Discussants: David H. Adams, Antonio Colombo, Ted E. Feldman, James B. Hermiller Jr, Scott Lim, Georg Nickenig
Challenging Case Winners 3: Mitral/LAA Case Adventures
12:00 pm
Transcatheter Closure of Incomplete Left Atrial Appendage Occlsuion (Previous Watchman LAA Occluder) - Implantation of a 2nd Generation ACP (Amulet) Device
Case Presenter: Simon Cheung Chi Lam
12:10 pm
Discussion
12:15 pm
Case Report from Bonn Germany with the Mitralign Annuloplasty System
Case Presenter: Georg Nickenig
12:25 pm
Discussion
12:30 pm
EchoNavigator for MitraClip: Use of A New Real-time Echo-Fluoro Overlay technology
Case Presenter: Sameer Gafoor
12:40 pm
Discussion
12:45 pm
First-in-man Simultaneous Left Atrial Appendage Ligation with Transapical TAVR
Case Presenter: Puvi Seshiah
12:55 pm
Discussion
1:00 pm
Mitraclip Bioskills 6
Lead Discussant: Mark Reisman
1:15 pm
Thoughtful Mitralclip Discussion
Moderators: Mark Reisman, Gregg W. Stone
Discussants: Robert R. Moss, John G. Webb, David A. Wood, Jian Ye
Mitral Day 2 (2:00 pm - 6:00 pm)
Friday, June 14
2:00 pm - 6:00 pm
Room: Bayshore Grand Ballroom
Section III. Functional MR
2:00 pm - 5:00 pm
Moderators: Steven F. Bolling, Scott Lim
Discussants: David H. Adams, Steven L. Goldberg, Karl-Heinz Kuck, Georg Nickenig, Alec S. Vahanian
2:00 pm
Bioskills Presentation: Pathology of Functional MR
Discussant: Mark Reisman
2:10 pm
Impact of Function MR on Outcomes in Ischemic and Idiopathic Dilated Cardiomyopathy: Major Culprit or Innocent Bystander?
2:25 pm
Surgery in Functional MR: Glass Half Full Perspectives
2:40 pm
Surgery in Functional MR: Glass Half Empty Perspectives
2:55 pm
Discussion with Audience Q&A
3:10 pm
Live Case 1: MitraClip in Functional MR, St. Paul's Hospital (Vancouver, Canada)
3:55 pm
MitraClip Outcomes in Functional in Functional MR (Low- and High-Risk Surgical Patients): Lessons Learned and Appropriate Patients
4:15 pm
MitraClip Technique Primer: Minimizing Residual MR, Complications and the Learning Curve
4:30 pm
Randomized Trials of the MitraClip in FMR: From COAPT to RESHAPE
4:45 pm
Discussion with Audience Q&A
Session IV. Emerging Transcatheter Mitral Valve Therapies
5:00 pm - 6:00 pm
Moderators: Eberhard Grube, Jason H. Rogers
Discussants: Anita Asgar, Maurice Buchbinder, Antonio Colombo, Joachim Schofer, Alec S. Vahanian
5:00 pm
Bioskills Presentation 2: Beyond the MitraClip
Discussant: Mark Reisman
5:15 pm
Progress with Transcatheter Mitral Valve Therapies (non-MitraClip, non-PerQ Valves)
5:35 pm
Rationale for and Progress with Percutaneous Mitral Valve Implants
5:45 pm
Discussion with Audience Q&A
Workshops
Novel Transcatheter Mitral Valve Therapies (8:00 am - 11:45 am)
Friday, June 14
8:00 am - 11:45 am
Room: Stanley Park Ballroom, Salon 3, 2nd Floor
Session I. The Principal Mitral TVT Contenders
8:00 am - 10:12 am
Moderators: Karl-Heinz Kuck, Gregg W. Stone
Discussants: Anita Asgar, Steven L. Goldberg, Paul A. Grayburn, Michael J. Mack, Francesco Maisano, Georg Nickenig, Joachim Schofer, Niel F. Starksen
8:00 am
Does Transcatheter Valve Therapy Need to Eliminate MR to Be Successful?
8:12 am
The History of Coronary Sinus Approaches: One Left Standing
8:27 am
Carillon Case (wtih Long-term Follow-up)
8:37 am
Discussion with Audience Q&A
8:47 am
Transatrial Annuloplasty: The Valtech Cardioband
9:02 am
Progress with the Mitralign Percutaneous Annuloplasty System: EU and US Studies
9:17 am
Basal Ventriculoplasty: Guided Delivery Systems' Accucinch
9:32 am
Discussion with Audience Q&A
9:42 am
Can the Coronary Sinus Approach or Annuloplasty "Work" in FMR? A Surgical Perspective
9:57 am
Combination TVT Techniques: MitraClip Plus
Session II. Alternative Mitral Valve TVT Approaches
10:12 am - 11:45 am
Moderators: Michael J. Mack, Gregg W. Stone
Discussants: Maurice Buchbinder, Scott Lim, Francesco Maisano, Jian Ye
10:12 am
The Promise and Reality of Surgical and Transcatheter Implantable Cords
10:27 am
Progress with the CardoSolutions Mitra-Spacer
10:42 am
Are Adjustable Valves (Surgical and Percutaneous) an Important Advance?
10:57 am
Description and Results of Valve-in-Valve for Degenerated Mitral Protheses
11:12 am
Transcatheter Mitral Valve Replacement: Rationale, Hurdles, and Devices
11:27 am
Panel Discussion with Audience Q&A
Special Session II. Valve-in-Valve Workshop for Bioprosthetic Valve (or Ring) Failure (8:30 am - 10:52 am)
Friday, June 14
8:30 am - 10:52 am
Room: Seymour Room, Lobby Level
Valve-in-Valve Workshop for Bioprosthetic Valve (or Ring) Failure
8:30 am - 10:52 am
8:30 am
Results and Lessons from the Global TAVR Valve-in-Valve Registry
Aortic Valve-in-Valve
8:42 am
Technology Considerations: Understanding the Anatomy of Aortic Bioprosthetic Surgical Valves
8:52 am
Procedural Tips and Clinical Outcomes using the Balloon-Expandable THV (Edwards): Taped Case from Vancouver
9:07 am
Procedural Tips and Clinical Outcomes using the Self-Expandable THV (CoreValve): Case Examples
9:19 am
Discussion with Audience Q&A
Mitral Valve-in-Valve and Rings
9:29 am
Mitral Valve-in-Valve (or Rings): How I Do the Transseptal Approach (Case Examples)
9:39 am
Technology Considerations: Understanding the Anatomy of Mitral Bioprosthetic Surgical Valves and Mitral/Tricuspid Rings
9:54 am
Procedural Tips and Clinical Outcomes using the Balloon-Expandable THV (Edwards): Taped Case from Vancouver
10:02 am
Mitral Valve-in-Valve (or Rings): How I Do the Transapical Approach
Case Presenter: Isaac George
10:10 am
Mitral Valve-in-Valve (or Rings): How I Do the Transseptal, Transapical Approach (Case Examples)
10:18 am
The Trans-apical Aortic and Mitral Valve-in-Valve (or ring) (Case Examples)
10:26 am
Mitral and Tricuspid Valve-in-Rings from the Global Registry
10:34 am
Tricuspid Valve-in-Valve (or ring): Techniques and Case Examples
10:42 am
Discussion with Audience Q&A
Challenging Cases III (10:30 am - 11:45 am)
Friday, June 14
10:30 am - 11:45 am
Room: Cypress Room, 2nd Floor
Agenda
10:30 am - 12:00 pm
Moderators: Alexandre Abizaid, E. Murat Tuzcu
Discussants: Nirat Beohar, Louis A. Cannon, Jeffrey W. Moses, Tamim Nazif
10:30 am
Acute RCA occlusion secondary to valve in valve deployment
Case Presenter: Vijay S Iyer
10:40 am
Discussion
10:45 am
Real-time Monitoring of an Intra-procedural Thrombus During Delivery of an Edwards SAPIEN Transcatheter Heart Valve
Case Presenter: Emil Missov
10:55 am
Discussion
11:00 am
When Size Does Matter: The First Case Of A TAVR Device Resheathing and Size Change
Case Presenter: Ian T. Meredith
11:10 am
Discussion
11:15 am
Transcatheter Aortic Valve implantation As Bridge to Heart Transplantation
Case Presenter: Giuseppe Bruschi
11:25 am
Discussion
11:30 am
Severe bicuspid aortic valve stenosis and very large aortic annulus treated with supraannular implantation of 31mm Medtronic CoreValve
Case Presenter: Wojciech Wojakowski
11:40 am
Discussion
Heart Team I. Best Practices for TAVR Program Clinical Operations (2:00 pm - 3:30 pm)
Friday, June 14
2:00 pm - 3:30 pm
Room: Stanley Park Ballroom, Salon 1-2, 2nd Floor
Agenda
2:00 pm - 3:30 pm
Moderator: Sandra Lauck
Discussants: Russell A. Brandwein, Marian C. Hawkey, Martina Kelly Speight, Karen Holst Lisby, Tamim Nazif, Susan J. Schnell, Julie K. Veasey
2:00 pm
The Role of the TAVR Coordinator: Essential to Sustained Program Success
2:10 pm
Supporting Case Selection: From Referral, Through Screening and Evaluation
2:20 pm
We can do it, but should we do it? Quantifying Frailty and Futility
2:30 pm
Meeting Education Needs: Patients, Families and interdisciplinary Teams
2:40 pm
The Heart Valve Clinic: A Central Component of Clinical Decision-Making
2:50 pm
Organizing the Heart Valve Clinical In-hospital Service: Practical Tips and Lessons
3:00 pm
Optimizing Post-procedure Care to Minimize Length of Stay
3:10 pm
Organizing the Cath Lab Heart Team: Establishing a Checklist Sequence
3:20 pm
Discussion/Q&A
Special Session III. Canadian Association of Interventional Cardiology Workshop (2:00 pm - 3:30 pm)
Friday, June 14
2:00 pm - 3:30 pm
Room: Seymour Room, Lobby Level
Canadian Association of Interventional Cardiology
2:00 pm - 3:30 pm
2:00 pm
Introduction
2:05 pm
TAVI Future Adaptations and Applications
2:23 pm
Patient selection for MitraClip: Who Benefits?
2:41 pm
Optimal vs. Essential Pre-TAVR Imaging: Peripheral Angio, Echo, and CT
2:59 pm
A Minimalist, Multidisciplinary, and Multimodality Approach to TAVR: Facilitating Early Discharge
3:15 pm
Discussion with Audience Q&A
Heart Team II. Challenges for TAVR Program Growth (4:00 pm - 5:30 pm)
Friday, June 14
4:00 pm - 5:30 pm
Room: Stanley Park Ballroom, Salon 1-2, 2nd Floor
Agenda
4:00 pm - 5:30 pm
Moderator: Marian C. Hawkey
Discussants: Leslie Achtem, Louis A. Cannon, Amanda Hill, Patricia E. Knipper, Sandra Lauck, Elizabeth M Perpetua, Elizabeth Walsh, David A. Wood
4:00 pm
Unique Challenges of Supporting TAVR Clinical Trials
4:10 pm
Careful Case Triaging for Next Day Discharge Following TAVR
4:20 pm
Alternative Access for TAVR: Emerging Best Practices and Clinical Support Requirements
4:30 pm
The Right Care for the Right Person: Integrating a Palliative Approach in TAVR Programs
4:40 pm
A Primer on Billing and Reimbursement after TAVR
4:50 pm
What a Geriatrician can do for TAVR Patients and Programs
5:00 pm
Experiences from a Start-up TAVR Center: Challenges and Rewards
5:10 pm
Discussion/Q&A
Saturday, June 15, 2013
General Sessions
Left Atrial Appendage (LAA) Session (8:00 am - 3:40 pm)
Saturday, June 15
8:00 am - 3:40 pm
Room: Bayshore Grand Ballroom
Session I. LAA Anatomy and Imaging
8:00 am - 8:40 am
Moderator: Rebecca T. Hahn
Discussants: John D. Carroll, Saibal Kar, Carlos E. Ruiz
8:00 am
Relational Aspects of LAA Anatomy
8:10 am
Basic Echo Imaging of the LAA with Fluoroscopic Correlation
8:20 am
CT Imaging of the LAA: Necessary for All or Device Specific?
8:30 am
Discussion with Audience Q&A
Session II. Setting the Stage
8:40 am - 10:20 am
Moderator: Matthew J. Price
Discussants: Maurice Buchbinder, Michael D. Ezekowitz, Ted E. Feldman, Steven L. Goldberg, Darryl S. Wells, Brian K. Whisenant
8:40 am
Defining Nonvalvular A-fib: Not So Simple
8:50 am
Surgical Methods and Outcomes for LAA Closure
9:00 am
"New" Anticoagulation Options for A-fib: Beyond Warfarin
9:15 am
EP Perspective: Where Will A-fib Ablation Take Us in the Next Five Years?
9:25 am
Review of Risk Scores and How They Guide Therapy
9:35 am
Who Is Really Contraindicated for Oral Anticoagulation Therapy? Are There Absolute Guidelines?
9:45 am
Is Triple Therapy a Triple Threat for Patients? DAPT and Chronic Anticoagulation
9:55 am
Management of the Patient with Chronic LAA Thrombus and/or Spontaneous Echo Contrast with Closure Devices
10:05 am
Discussion with Audience Q&A
Session III. Imaging the LAA: Procedural Guidelines
10:20 am - 11:00 am
Moderator: John D. Carroll
Discussants: Rebecca T. Hahn, Mark Reisman, Brian K. Whisenant
10:20 am
Understanding LAA Anatomy for Optimal Device Selection
10:30 am
TEE Imaging for LAA Closure
10:40 am
Integrating TEE and Fluoroscopy for LAA Therapies
10:50 am
Discussion with Audience Q&A
Session IV. Techniques and Devices for LAA Occlusion
11:00 am - 12:30 pm
Moderator: Steven J. Yakubov
Discussants: Matthew J. Price, Mark Reisman, Jacqueline Saw, Horst Sievert, Brian K. Whisenant
11:00 am
Optimal Transseptal Technique for LAA Occlusion
11:10 am
Optimal Technique for Pericardial Access
11:20 am
Current and (Near) Future Devices: Does Design Dictate Choice?
11:35 am
Case Presentation: Amplatzer Cardiac Plug (St. Jude Medical)
Case Presenter: Jacqueline Saw
11:45 am
Case Presentation: Watchman (Boston Scientific)
Case Presenter: Mark Reisman
11:55 am
Case Presentaton: Lariat (SentreHEART)
Case Presenter: Matthew J. Price
12:05 pm
Case Presentation: Wavecrest (Coherex Medical)
Case Presenter: Brian K. Whisenant
12:15 pm
Discussion with Audience Q&A
Session V. Watchman Clinical Program
12:30 pm - 1:20 pm
Moderator: Mark Reisman
Discussants: Maurice Buchbinder, Ted E. Feldman, Saibal Kar
12:30 pm
The Watchman Device: Form vs. Function
12:40 pm
Keynote Address: Interpreting PROTECT AF, CAP, and PREVAIL: Who Is the Ideal Patient?
12:55 pm
How to Avoid Complications with the Watchman Device
1:05 pm
Discussion with Audience Q&A
Session VI. Future Evolution and Challenges of LAA Closure
1:20 pm - 2:25 pm
Moderator: Horst Sievert
Discussants: William A. Gray, Martin B. Leon, Matthew J. Price, Jason H. Rogers, Jacqueline Saw
1:20 pm
LAA Closure for the Anticoagulation Intolerant Patient: Data and Common Sense
1:30 pm
Sentreheart: A Leap from Ligation to Stroke Reduction: Treatment Recommendations in the Absence of a Trial
1:40 pm
Residual Leaks and Thrombus Formation
1:50 pm
Emerging Therapies for LAA Occlusion: The New Devices
2:00 pm
Mixed Marriage: TAVR and LAA Occlusion
2:10 pm
Discussion with Audience Q&A
Session VII. Provocative and Challenging Cases
2:25 pm - 3:25 pm
Moderator: Saibal Kar
Discussants: Michael D. Ezekowitz, Matthew J. Price, Jason H. Rogers, Darryl S. Wells
2:25 pm
Complex LAA Anatomy (Watchman Closure): Chicken Wing Morphology
Case Presenter: Steven J. Yakubov
2:32 pm
Case Discussion
2:40 pm
Complication of LAA Closure: Lariat (SentreHEART)
Case Presenter: Matthew J. Price
2:47 pm
Case Discussion
2:55 pm
Complication of LAA Closure: Watchman (Boston Scientific)
Case Presenter: Mark Reisman
3:02 pm
Case Discussion
3:10 pm
Postprocedure Thrombus
Case Presenter: Ted E. Feldman
3:17 pm

The Conference
